Skip Navigation

Dawn N. Ward , Ph.D.

Associate Professor
Chemistry | Fine School of the Sciences
Dawn Ward
Contact
Office Hours
M, T, and W: 12-1
Office Location
  • Kevin J. Manning Academic Center
  • Room N107
  • Owings Mills North
Campus Map

Education

  • Ph.D., Synthetic Organic Chemistry, University of Maryland, Baltimore County (2009)
  • B.A., with Honors in Chemistry, Lincoln University, Pennsylvania (1995)

Professional Experience

  • STEVENSON UNIVERSITY
  • Associate Professor
  • 2009-Present
  • CCBC, Catonsville Campus
  • Adjunct Professor
  • 2009

Research

The focus of my current research is the synthesis of heterocyclic compounds containing metal binding properties for uses in the areas of medicinal chemistry and organic sensors and semiconductors. In the area of medical chemistry, the research goals are to synthesize derivatives that have improved metal binding efficiency and inhibition rates over a series of Hepatitis C Virus inhibitors. I am also interested synthesizing organic heterocyclic compounds as chemical sensors for detection of heavy metals.

Publications

 Naanaa, A. M.*; Chen, R*.; Smith, B.*; Wong, R.*; Ward, D. N. Improving the metal-binding efficiency of heterocyclic compounds targeting metal ion-dependent enzyme of hepatitis C virus. In Abstracts of Papers, 249th ACS National Meeting & Exposition, Denver, CO, United States, March 22-26, 2015; American Chemical Society, 2015; p ORGN – 355.

 Drazenovic, R. M.*; Ward, D. N.; Smith, P. J.; Sonnenberg, J. L. Structure and bonding of metal complexes containing possible hepatitis C inhibitors. In Abstracts of Papers, 249th ACS National Meeting & Exposition, Denver, CO, United States, March 22-26, 2015; American Chemical Society, 2015; p PHYS – 438.

Ward, D. N.; Talley, D. C.; Tavag, M.*; Menji, S.*; Schaughency, P.*; Baier, A.; Smith, P. J. UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication. Bioorg. Med. Chem. Lett. 2014, 24 (2), 609–612.

Smith, Paul J. and Ward, Dawn N. Heterocyclic benzoxazole compositions as inhibitors of hepatitis C virus and synthesis and pharmaceutical compositions. From PCT Int. Appl., WO 2011047390, 21 Apr 2011 and United States Patent Appl. Pub. US 2012/0208856 A1, 16 Aug, 2012. 

O’Malley, K. W.*; Ward, D. N.; Smith, P. J. Synthesis of new Heterocyclic Inhibitors of the Helicase of Hepatitis C Virus. In Abstracts, 41st Middle Atlantic Regional Meeting of the American Chemical Society, Wilmington, DE, United States, April 10-13; American Chemical Society, 2010; p MARM – 189.

Ward, D. N.; Bekkerman, M.*; Blasic, J. R.; Lubet, P*.; Menji, S.*; Schaughency, P.*; Tavag, M.*; Smith, P. J. Exploiting metal binding by UK-1: Synthesis of potential HIV-1 integrase inhibitors. In Abstracts of Papers, 234th ACS National Meeting, Boston, MA, United States, August 19-23, 2007; American Chemical Society, 2007; p ORGN – 134.

*Undergraduate Co-Author

Teaching

Chem 210: Organic Chemistry I

Chem 210L: Organic Chemistry I Laboratory

Chem 211: Organic Chemistry II

Chem 211L: Organic Chemistry II Laboratory

Chem 213: Electronic Literature Search

Chem 313: Career Development in Chemistry

DISCLAIMER: The content of this faculty profile page was created, authored, and published by the identified faculty member. Stevenson University (SU) makes absolutely no guarantee as to the currency, accuracy, or quality of information published. The views and opinions expressed on this page or any links made available are strictly those of the author and do not necessarily state or reflect those of SU. The content of this profile page has not been reviewed or approved by Stevenson University.